Ticagrelor Pharmazac

Ticagrelor Pharmazac is an oral antiplatelet medication used to prevent blood clots in patients with heart conditions. It belongs to the P2Y12 inhibitor class and supports cardiovascular health. This EU-manufactured generic helps reduce the risk of heart attack and stroke. Suitable for adults with specific heart-related risks.

Ticagrelor is primarily used to reduce the risk of heart attack and stroke in patients with acute coronary syndromes or a history of heart disease. It works by preventing blood platelets from clumping together, which can block arteries. People often ask, 'what is ticagrelor used for' to understand its role in managing cardiovascular risks. It may also be prescribed after stent placement to maintain artery openness.

Ticagrelor helps maintain healthy blood flow by reducing the likelihood of blood clots forming in the arteries. Users may notice improved circulation and reduced chest discomfort associated with heart conditions. Some people report mild effects like shortness of breath or dizziness, which are generally temporary. Regular use supports long-term cardiovascular stability.

Ticagrelor should be taken exactly as prescribed, usually twice daily with or without food. Avoid sudden discontinuation unless directed by a healthcare professional, as this may increase clot risk. Inform your doctor about any bleeding disorders or upcoming surgeries. Store in a cool, dry place away from direct light.

Ticagrelor may interact with other blood thinners, NSAIDs, or certain antidepressants, increasing bleeding risk. Strong CYP3A4 inhibitors like ketoconazole may raise ticagrelor levels, while inducers like rifampin can reduce its effectiveness. Alcohol and grapefruit products may also affect how it works. Always disclose all medications to your healthcare provider.